Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.6011
Delayed Data
As of 3:59pm ET
 +0.062 / +11.50%
Today’s Change
0.36
Today|||52-Week Range
1.00
+61.50%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.54
Today’s open0.54
Day’s range0.53 - 0.60
Volume6,283,633
Average volume (3 months)8,750,062
Market cap$89.3M
Dividend yield--
Data as of 3:59pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+35.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+100.00%
P/E ratioNM
Price/Sales150.86
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
CFRXContraFect Corp0.000.00%
PFNXPfenex Inc-0.09-2.59%
SRRASierra Oncology Inc0.000.00%
ADMAADMA Biologics Inc+0.10+3.46%
Data as of 7:59pm ET, 08/23/2017

Financials

Last reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$200.0K
Annual profit (last year)-$50.8M
Net profit margin-25,385.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts